Xencor Inc
XNCRHealthcare|Biotechnology|USA
$15.86
-0.27 (-1.64%)
Tangible Book
$6.86
About
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Stock Price
+70.9%(1Y)
Pipeline Summary
34 total trials26
Phase 1
11
Phase 2
0
Phase 3
0
Phase 4
Completed: 16Terminated: 9Recruiting: 5Active: 2NOT_YET_RECRUITING: 1Withdrawn: 1
Active Trials (7)
A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
NCT07284797Healthy
Phase 1Recruiting
Enrollment: 60 participants
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
NCT06276491Ovarian Cancer
Phase 1Recruiting
Enrollment: 282 participants
XmAb20717 in Advanced Biliary Tract Cancers
NCT05297903Biliary Tract Cancer
Phase 2Active
Enrollment: 27 participants
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
NCT06619990Ulcerative Colitis (UC)
Phase 1Phase 2Recruiting
Enrollment: 270 participants
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
NCT05032040Ovarian Cancer
Phase 2Active
Enrollment: 170 participants
BioScore
4.2/10
Cautious
Ownership
Recent Insider Trades
Feigal EllenSELL
2026-06-186,843 shares @ $13.06
RANIERI RICHARD JSELL
2026-06-155,474 shares @ $12.31
Montgomery Alan BruceSELL
2026-06-155,064 shares @ $12.31
GUSTAFSON KURT ASELL
2026-06-155,474 shares @ $12.31
GORMAN KEVIN CHARLESSELL
2026-06-157,527 shares @ $12.31
Recent News
2026-07-07 13:07:23
2026-06-22 22:01:14
2026-06-17 22:03:51
Data last updated: Jul 13, 2026, 12:47 PM